Targeting the EWS–FLI1 transcription factor in Ewing sarcoma

被引：0
|
作者：
R. Tancredi
A. Zambelli
G. A. DaPrada
V. Fregoni
L. Pavesi
A. Riccardi
S. Burdach
P. J. Grohar
M. D’Incalci
机构：
[1] I.R.C.C.S. Salvatore Maugeri Foundation,Medical Oncology Unit
[2] Piazza OMS - Organizzazione Mondiale della Sanità,Medical Oncology Unit, Azienda Ospedaliera Giovanni XXIII
[3] 1,Medical Oncology Unit, Department of Internal Medicine
[4] University of Pavia,Department of Pediatrics and Children’s Cancer Research Center (CCRC)
[5] Technische Universität München (TUM),Laboratory of Cancer Pharmacology, Department of Oncology
[6] Monroe Carrell Jr. Children’s Hospital and the Vanderbilt Ingram Cancer Center,undefined
[7] IRCCS-Istituto di Ricerche Farmacologiche Mario Negri,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Ewing sarcoma; Trabectedin; Irinotecan; Combination therapy; Transcription mechanism; Werner gene; EWS–FLI1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1317 / 1320
页数：3
相关论文
共 50 条
  • [21] EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells
    Hu, Hsien-Ming
    Zielinska-Kwiatkowska, Anna
    Munro, Karen
    Wilcox, Jason
    Wu, Daniel Y.
    Yang, Liu
    Chansky, Howard A.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2008, 26 (06) : 886 - 893
  • [22] The EWS/FLI1 transcriptome is characterized by marked heterogeneity across Ewing sarcoma cell lines
    Kitchen-Goosen, Susan M.
    Bowman, Megan J.
    Adams, Marie
    Berger, Penny
    Grohar, Patrick J.
    CANCER RESEARCH, 2018, 78 (13)
  • [23] EWS/FLI1 regulates tumor anglogenesis in Ewing's sarcoma via suppression of thrombospondins
    Potikyan, Garv
    Savene, Rupert O. V.
    Gaulden, Julie M.
    France, Kelly A.
    Zhou, Zhichao
    Kleinerman, Eugenie S.
    Lessnick, Stephen L.
    Denny, Christopher T.
    CANCER RESEARCH, 2007, 67 (14) : 6675 - 6684
  • [24] Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma
    Yodoya, Noriko
    Iwamoto, Shotaro
    Matsumine, Akihiko
    Azuma, Eiichi
    Toyoda, Hidemi
    Miura, Yoshihiro
    Nakatani, Kaname
    Imai, Hiroshi
    Hirayama, Masahiro
    Komada, Yoshihiro
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (01) : 6 - 9
  • [25] Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing Sarcoma
    Hong, Sung-Hyeok
    Youbi, Sarah. E.
    Hong, S. Peter
    Kallakury, Bhaskar
    Monroe, Phillip
    Erkizan, Hayriye V.
    Barber-Rotenberg, Julie S.
    Houghton, Peter
    Uren, Aykut
    Toretsky, Jeffrey A.
    ONCOTARGET, 2014, 5 (02) : 338 - 350
  • [26] Hijacking the BAF complex: the mechanistic interplay of ARID1A and EWS::FLI1 in Ewing sarcoma
    Sohn, Erich J.
    Libich, David S.
    MOLECULAR ONCOLOGY, 2024,
  • [27] Menin and EWS/FLI1 activate serine biosynthesis via ATF4 in Ewing sarcoma
    Jimenez, Jennifer A.
    Ruiz, Ramon Ocadiz
    Apfelbaum, April
    Kumar, Abhijay
    Kerk, Samuel
    Grembecka, Jolanta
    Lyssiotis, Costas A.
    Lawlor, Elizabeth R.
    CANCER RESEARCH, 2020, 80 (14) : 99 - 99
  • [28] Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blotting
    Wang, M
    Nilsson, G
    Carlberg, M
    Dricu, A
    Wejde, J
    Kreicbergs, A
    Larsson, O
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 432 (02): : 131 - 134
  • [29] Targeting EWS/FLI fusion oncoprotein stability/degradation in Ewing sarcoma
    Seong, Bo Kyung Alex
    Lin, Shan
    Donovan, Katherine
    Robichaud, Amanda
    Stolte, Bjorn
    Wang, Emily
    Dharia, Neekesh
    Nabet, Behnam
    Piccioni, Federica
    Gray, Nathanael
    Fischer, Eric
    Stegmaier, Kimberly
    CANCER RESEARCH, 2020, 80 (14) : 105 - 106
  • [30] EWS/FLI1 activates GLI1 indirectly through GLI2 in Ewing Sarcoma
    Christensen, Laura
    May, William A.
    CANCER RESEARCH, 2016, 76
12345